VeronicaBritoMD

Pulmonology • Temple, TX

Critical Care Medicine, Cystic Fibrosis, Sleep Medicine

Physician

Join to view full profile

Dr. Brito is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brito's full profile

Already have an account?

Office
2401 S 31st St
Temple, TX 76508
Phone+1 254-724-2111

Fax+1 254-724-4153

Education & Training

NYU Grossman Long Island School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
NYU Grossman Long Island School of MedicineFellowship, Sleep Medicine, 2008 - 2009
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2003 - 2007
Fluminense Federal University Faculty of MedicineClass of 1999

Certifications & Licensure

TX State Medical License 2012 - 2026
NY State Medical License Active through 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Clinical Trials

Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia Start of enrollment: 2009 Jun 01
Completed

Publications & Presentations

PubMed

3 citations
Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia.
Waqas Aslam, Naomi E Mathew, Courtney Shaver, Veronica Brito, Shirley F. Jones
American Journal of Therapeutics. 2021-07-01
27 citations
Aspiration risk factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
Judith Marin-Corral, Sergi Pascual-Guardia, Francesco Amati, Stefano Aliberti, Joan R. Masclans
Chest. 2021-01-01
38 citations
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial...
Takaya Maruyama, Takao Fujisawa, Tadashi Ishida, Akihiro Ito, Yoshitaka Oyamada
Clinical Infectious Diseases. 2019-03-19

Journal Articles

A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter- Cohort Study Using Risk Factors for Multidrug Resistant Pathogens to Select Initia...
Michael S Niederman, Veronica Brito, Clinical Infectious Diseases